Roxadustat clinical trials
Also written FG-4592 and ASP1517.
How each study uses roxadustat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the roxadustat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- 18 Aug 2021 · Evrenzo · EMEA/H/C/004871 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
62 studies that test it; most in 2016 (8); 1 more planned to start later
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 6 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 8 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 47 · Other 16
FibroGen (21) · Astellas Pharma Inc (13) · Astellas Pharma Europe B.V. (7) · AstraZeneca (3) · Astellas Pharma Global Development, Inc. (2) · Peking University First Hospital (2) · Mansoura University (2) · Peking Union Medical College Hospital (2)
Often tested with
Tested in the same studies.
Darbepoetin alfa (2) · Lanthanum carbonate (1) · AST 120 (1) · Charcoal (1) · Sacubitril valsartan (1) · Erythropoietin (1) · Tretinoin (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 4, 2 in phase 3
Studies that test roxadustat, phase 3 first.
- Nov 2026Effect of Perioperative Roxadustat in Elective Lumbar Interbody Fusion Surgery.Phase 3 · Second Affiliated Hospital, School of Medicine, Zhejiang University
- Oct 2027A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney DiseasePhase 3 · Astellas Pharma Global Development, Inc.
- Jan 2027The Effect of Roxadustat on Renal Oxygenation in Diabetes NephropathyPhase 2 · Region Stockholm
- Nov 2027Roxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass SurgeryPhase 4 · Peking University First Hospital
Studies
Open first, then newest update. How each study uses roxadustat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 63
- Roxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass SurgeryNot yet recruitingPhase 4Peking University First HospitalNCT07912801Written as Roxadustat
- A Study to Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating Anemia in Participants With Myelodysplastic Syndromes (MDS)Not yet recruitingPhase 3Kyntra BioNCT07722988Written as Roxadustat
- Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis PatientsNot yet recruitingPhase 4Tianjin Medical University General HospitalNCT07162090Written as Roxadustat
- Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis PatientsRecruitingPhase 1/2Mansoura UniversityNCT06903559Written as Roxadustat
- Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis PatientsRecruitingPhase 1/2Mansoura UniversityNCT06917950Written as Roxadustat
- The Effect of Roxadustat on Renal Oxygenation in Diabetes NephropathyNot yet recruitingPhase 2Region StockholmNCT05810311Written as Roxadustat
- A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney DiseaseActive, not recruitingPhase 3Astellas Pharma Global Development, Inc.NCT05970172Written as Roxadustat
- Roxadustat Versus Erythropoietin for Anaemia Treatment in Diabetic NephropathyCompletedNot applicableHanzla ArshadNCT07786168Written as Roxadustat
- A Single-arm Trial of Roxadustat Combined With Retinoic Acid in the Treatment of Refractory Low-risk MDSWithdrawnPhase 1/2Peking Union Medical College HospitalNCT06020833Written as Roxadustat in combination with retinoic acid
- Effect of Low Doses of Hypoxia-inducible Factor- Prolyl Hydroxylase Enzyme Inhibitor Plus Iron in the Treatment of Anemia in Dialysis-dependent Chronic Kidney Disease PatientsCompletedPhase 4Alexandria UniversityNCT06115421Written as Roxadustat
- Study of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney DiseaseCompletedPhase 4Second Xiangya Hospital of Central South UniversityNCT07359027Written as Roxadustat
- Study of Roxadustat for Reducing the Incidence of Acute Kidney Injury After Coronary Artery Bypass GraftingTerminatedPhase 2Peking Union Medical College HospitalNCT05010460Written as Roxadustat
- Effect of Perioperative Roxadustat in Elective Lumbar Interbody Fusion Surgery.Active, not recruitingPhase 3Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT06772272Written as Roxadustat
- Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable DialysisCompletedPhase 3Astellas Pharma Europe B.V.NCT02278341Written as Roxadustat
- Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin AlfaCompletedPhase 3Astellas Pharma Europe B.V.NCT02021318Written as Roxadustat
- Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring DialysisCompletedPhase 3Astellas Pharma Europe B.V.NCT01887600Written as Roxadustat
- A Study of Intermittent Oral Dosing of ASP1517 in Non-Dialysis Chronic Kidney Disease Patients With AnemiaCompletedPhase 3Astellas Pharma IncNCT02988973Written as roxadustat
- A Study to Assess the Relative Bioavailability of Roxadustat Following a Single Dose of Pediatric Azo Dye-free Tablet Formulation and Pediatric Azo Dye-free Mini-tablet Formulation Compared to a Single Dose of Azo Dye-containing Tablet Formulation in Healthy Adult SubjectsCompletedPhase 1Astellas Pharma Global Development, Inc.NCT03960489Written as Roxadustat
- A Study of Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With AnemiaCompletedPhase 3Astellas Pharma IncNCT02964936Written as roxadustat
- A Long Term Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia Converted From Erythropoieses Stimulating Agent (ESA) TreatmentCompletedPhase 3Astellas Pharma IncNCT02779764Written as roxadustat
See all 63 studies that test roxadustat →
Given beside what is tested · 1 — roxadustat is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with roxadustat
What changed recently
From the registry's own updates since Oct 18, 2026.
Newly registered1
- Roxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass SurgeryNov 3, 2026NCT07912801
Codes
What other systems call roxadustat · ClinicalTrials.gg INT006377
- MeSH (NLM) C584543roxadustatOne source NLM
- UNII (FDA) X3O30D9YMXROXADUSTATConfirmed FDA, NLM, Wikidata
- Wikidata Q27088611roxadustatConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C141436RoxadustatOne source FDA
- DrugBank DB04847One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C584543 | roxadustat | One source NLM |
| UNII (FDA) | X3O30D9YMX | ROXADUSTAT | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27088611 | roxadustat | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C141436 | Roxadustat | One source FDA |
| DrugBank | DB04847 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.